Guideline recommendedatherapy | Guideline adherentbtherapy | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Univariable analysis | Multivariable analysisN = 1002, GP = 145, ICC = 0.29 | Univariable analysis | Multivariable analysisN = 1095, GP = 154, ICC = 0.31 | |||||||
GP characteristics | N, GP | OR (95% CI) | p-value | OR (95% CI) | p-value | N, GP | OR (95% CI) | p-value | OR (95% CI) | p-value |
Sex of GP = female | 1067, 156 | 1.28 (0.67, 2.42) | 0.458 | 1155, 161 | 1.22 (0.64, 2.34) | 0.549 | ||||
Age of GP | 1023, 150 | 0.95 (0.92, 0.98) | 0.003 | 0.96 (0.93, 0.99) | 0.010 | 1107, 155 | 0.95 (0.92, 0.98) | 0.005 | 0.96 (0.92, 0.99) | 0.012 |
Years of GP experience in practice | 991, 146 | 0.96 (0.93, 0.99) | 0.023 | 1066,150 | 0.96 (0.94, 0.996) | 0.028 | ||||
Practice type (ref = Single) | 1052, 154 | |||||||||
Double | 2.06 (0.93, 4.54) | 0.073 | 1139, 159 | 2.13 (0.96, 4.75) | 0.064 | |||||
Group | 2.00 (1.02, 3.90) | 0.044 | 1.93 (0.98, 3.81) | 0.059 | ||||||
Work-time % (ref = < 60%) | ||||||||||
61–80% | 1046, 153 | 1.05 (0.44, 2.51) | 0.919 | 1133, 158 | 1.06 (0.44, 2.57) | 0.894 | ||||
81–100% | 0.43 (0.21, 0.90) | 0.026 | 0.44 (0.21, 0.92) | 0.029 | ||||||
Affiliated to a medical network | 1052, 154 | 1.16 (0.62, 2.17) | 0.633 | 1139, 159 | 1.10 (0.58, 2.06) | 0.772 | ||||
Language of GP (ref = German) | ||||||||||
Latin | 1067, 156 | 1.18 (0.50, 2.78) | 0.703 | 1155, 161 | 1.10 (0.46, 2.63) | 0.823 | ||||
Location of GPc (ref = Other regions) | ||||||||||
Region lemanique | 1067, 156 | 2.58 (0.78, 8.54) | 0.120 | 2.30 (0.71, 7.43) | 0.165 | 1155,161 | 2.50 (0.74, 8.39) | 0.139 | 2.29 (0.69, 7.57) | 0.176 |
Ticino | 0.34 (0.06, 1.98) | 0.228 | – | 0.32 (0.05, 1.93) | 0.214 | 0.36 (0.06, 2.06) | 0.249 | |||
Zürich | 2.65 (1.08, 6.51) | 0.033 | 2.19 (0.87, 5.48) | 0.095 | 2.78 (1.13, 6.85) | 0.026 | 2.33 (0.92, 5.92) | 0.074 | ||
Patient characteristics | N | N | ||||||||
Previous urinary tract infection | 1114 | 1.22 (0.79, 1.84) | 0.362 | 1202 | 1.22 (0.79, 1.83) | 0.361 | ||||
Antibiotics in the last 3 months | 1112 | 0.75 (0.53, 1.09) | 0.125 | 1198 | 0.74 (0.52, 1.07) | 0.101 | 0.71 (0.46, 1.10) | 0.123 | ||
Treatment in the last 6 months | 1117 | 0.84 (0.51, 1.46) | 0.518 | 1204 | 0.83 (0.51, 1.44) | 0.498 | ||||
Travel history within the last 12 months | 1100 | 1.59 (1.14, 2.22) | 0.006 | 1.30 (0.88, 1.93) | 0.187 | 1187 | 1.59 (1.15, 2.21) | 0.005 | ||
Travel within Europe | 1100 | 1.64 (1.17, 2.29) | 0.004 | 1187 | 1.62 (1.17, 2.26) | 0.004 | ||||
Travel to Asia | 1100 | 0.84 (0.47, 1.64) | 0.591 | 1187 | 0.93 (0.52, 1.80) | 0.826 | ||||
Travel to Africa | 1100 | 2.07 (0.73, 8.66) | 0.232 | 1187 | 2.31 (0.83, 9.6) | 0.167 | ||||
Travel to Nord-America | 1100 | 1.41 (0.60, 4.15) | 0.473 | 1187 | 1.37 (0.58, 4.00) | 0.516 | ||||
Travel to South-America | 1100 | 0.80 (0.35, 2.17) | 0.626 | 1187 | 0.73 (0.32, 1.99) | 0.502 | ||||
Initial encounter not because symptoms suspicious for an UTI | 1115 | 1.23 (0.65, 2.59) | 0.554 | 1202 | 1.36 (0.72, 2.85) | 0.369 |